Ligand validation:6R2R

BYN: hydroxylated prenyl-FMN

BYN is a Ligand Of Interest in 6R2R designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6R2R_BYN_A_604	95%	17%	0.081	0.985	1.93	1.7	6	9	5	0	100%	0.9784
6R3L_BYN_A_605	99%	12%	0.05	0.987	2.1	1.92	7	12	1	0	100%	0.7
6TIJ_BYN_AAA_604	99%	13%	0.056	0.991	2.51	1.44	5	6	4	0	100%	0.9811
6EV8_BYN_A_604	99%	25%	0.057	0.987	1.58	1.5	5	5	2	0	100%	0.9865
6TIH_BYN_AAA_604	98%	9%	0.067	0.989	2.78	1.79	7	9	5	0	100%	0.9811
8OED_BYN_A_601	98%	43%	0.059	0.979	0.84	1.37	1	4	1	0	100%	1
6TIB_BYN_AAA_604	97%	17%	0.073	0.989	1.84	1.8	8	12	1	0	100%	0.9811

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.